* Enfusion Inc ENFN.N reported quarterly adjusted earnings
of 6
cents per share for the quarter ended in March, higher than
the same quarter last year, when the company reported EPS of 2
cents. The mean expectation of eight analysts for the quarter
was for earnings of 4 cents per share. Wall Street expected
results to range from 2 cents to 4 cents per share.
* Revenue rose 17.3% to $48.05 million from a year ago;
analysts
expected $47.62 million.
* Enfusion Inc's reported EPS for the quarter was a loss of
1
cent.
* The company reported a quarterly loss of $539 thousand.
* Enfusion Inc shares had risen by 5.6% this quarter and
gained 0.7% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by
about 27.5%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 2
"hold" and 3 "sell" or "strong sell."
* The average consensus recommendation for the software peer
group
is also "hold"
Wall Street's median 12-month price target for Enfusion Inc is
$9.88
This summary was machine generated from LSEG data May 9 at 02:43
p.m. UTC. All figures in US dollars unless otherwise stated.
(For questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Mar. 31 2024 0.04 0.06 Beat
Dec. 31 2023 0.05 0.04 Missed
Sep. 30 2023 0.05 0.04 Missed
Jun. 30 2023 0.04 0.04 Met